Cara Therapeutics

May 29, 2019

Positive data Kalm Cara investors

Cara Therapeutics’ stock shot up 18% today on data derisking two key projects.

February 15, 2019

Upcoming events – Pivotal data for Galapagos and Cara

Galapagos will discover if filgotinib can hang on to its reputation as one of the safest Jak inhibitors in the industry, while Cara is itching for pivotal trial success…

June 27, 2018

More pain for Pain, but Cara saves face for now

June 30, 2017

Snippet roundup: Clinical disappointments for Cara, Bioclin and Sumitomo

May 26, 2016

Innocoll sponges up goodwill after pain success

April 22, 2016

Upcoming events – Cara, Heron and Seres get ready for next phase

April 03, 2014

Biotech floats hint at a narrowing gap between perception and reality

April 01, 2014

Biotech’s record-breaking quarter shines spotlight on sustainability